Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Lamotrigine Effects on Brain Function
NCT04156035Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2020
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in major depressive disorder (MDD) comparing Lamotrigine + Ketamine, Placebo + Ketamine and Placebo + Placebo (3 arms). Primary endpoint: Functional brain changes induced by emotional and cognitive challenge. Started Mar 2020; status: completed.
02
Drugs
ketamine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04156035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156035.